RNA-Seq identifies SPGs as a ventral skeletal patterning cue in sea urchins by Piacentino, Michael L. et al.
Boston University
OpenBU http://open.bu.edu
BU Open Access Articles BU Open Access Articles
2016-02-15
RNA-Seq identifies SPGs as a
ventral skeletal patterning cue in
sea urchins
This work was made openly accessible by BU Faculty. Please share how this access benefits you.
Your story matters.
Version
Citation (published version): Michael L Piacentino, Daniel T Zuch, Julie Fishman, Sviatlana Rose,
Emily E Speranza, Christy Li, Jia Yu, Oliver Chung, Janani
Ramachandran, Patrick Ferrell, Vijeta Patel, Arlene Reyna, Hajerah
Hameeduddin, James Chaves, Finnegan B Hewitt, Evan Bardot, David
Lee, Amanda B Core, John D Hogan, Jessica L Keenan, Lingqi Luo,
Jasmin Coulombe-Huntington, Todd A Blute, Ekaterina Oleinik, Jonas
Ibn-Salem, Albert J Poustka, Cynthia A Bradham. 2016. "RNA-Seq
identifies SPGs as a ventral skeletal patterning cue in sea urchins.."
Development, Volume 143, Issue 4, pp. 703 - 714.
https://hdl.handle.net/2144/28956
Boston University
RESEARCH ARTICLE
RNA-Seq identifies SPGs as a ventral skeletal patterning cue in
sea urchins
Michael L. Piacentino1,2, Daniel T. Zuch1,2, Julie Fishman1, Sviatlana Rose1, Emily E. Speranza3, Christy Li1,
Jia Yu1, Oliver Chung1, Janani Ramachandran1, Patrick Ferrell1, Vijeta Patel1, Arlene Reyna1,
Hajerah Hameeduddin1, James Chaves1, Finnegan B. Hewitt1, Evan Bardot1, David Lee1, Amanda B. Core1,
John D. Hogan3, Jessica L. Keenan3, Lingqi Luo3, Jasmin Coulombe-Huntington3, Todd A. Blute1,4,
Ekaterina Oleinik5, Jonas Ibn-Salem6, Albert J. Poustka6,7 and Cynthia A. Bradham1,2,3,*
ABSTRACT
The sea urchin larval skeleton offers a simple model for formation of
developmental patterns. The calcium carbonate skeleton is secreted
by primary mesenchyme cells (PMCs) in response to largely
unknown patterning cues expressed by the ectoderm. To discover
novel ectodermal cues, we performed an unbiased RNA-Seq-based
screen and functionally tested candidates; we thereby identified
several novel skeletal patterning cues. Among these, we show that
SLC26a2/7 is a ventrally expressed sulfate transporter that promotes
a ventral accumulation of sulfated proteoglycans, which is required for
ventral PMC positioning and skeletal patterning. We show that the
effects of SLC perturbation are mimicked by manipulation of either
external sulfate levels or proteoglycan sulfation. These results identify
novel skeletal patterning genes and demonstrate that ventral
proteoglycan sulfation serves as a positional cue for sea urchin
skeletal patterning.
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INTRODUCTION
Patterning the larval skeleton in sea urchin embryos is a
communication-based process in which statically positioned
ectodermal cells direct the migration and positioning of primary
mesenchymal cells (PMCs), which secrete a calcium carbonate
skeleton via biomineralization (Lyons et al., 2012). During
gastrulation, the PMCs ingress into the blastocoel, then migrate
and organize into a posterior ring around the blastopore, with two
ventrolateral clusters from which PMCs migrate anteriorly to form
ventrolateral cords. This initial ring-and-cords PMC organization
gives rise to the primary skeletal elements, whereas additional
migration out of this pattern is required to form the secondary
skeletal elements (see Fig. S7A,B for schematics illustrating
primary and secondary skeletal patterning).
von Ubisch first suggested that the ectoderm provides patterning
instructions to the PMCs in the 1930s (von Ubisch, 1937) and in
the early 1960s, Gustafson and Wolpert demonstrated that the
posterior PMC ring is actively positioned by posteriorizing the
ectoderm and showing that the ring was correspondingly
repositioned anteriorly (Gustafson and Wolpert, 1999). In the
1990s, Hardin and colleagues showed that treatment with nickel
provokes skeletal patterning defects (Hardin et al., 1992).
Armstrong, Hardin and McClay later used microsurgical
transplants to demonstrated that the nickel-mediated patterning
defect was specific to the ectoderm and not the PMCs (Armstrong
et al., 1993). Subsequent experiments have confirmed and
corroborated these results (reviewed by Adomako-Ankomah and
Ettensohn, 2014; McIntyre et al., 2014). Throughout their
migration, the PMCs extend thin filopodia that contact the
ectoderm (Gustafson and Wolpert, 1999; Miller et al., 1995).
These observations led to the widely accepted hypothesis that the
filopodia act as conduits for receiving patterning information from
the ectoderm.
Recent studies have identified ectodermal genes whose products
regulate PMC migration and skeletogenesis. These include the
tripartite motif-containing protein Strim1, the transcription factors
Pax2/5/8 and Otp, the signaling ligands FGF, Wnt5a, VEGF and
the TGF-β ligand Univin. These genes are expressed in the
ectoderm directly adjacent to sites of active biomineralization and
with the exception of Univin, which is specifically required for
patterning of the secondary skeletal elements (Piacentino et al.,
2015), their loss of function (LOF) blocks skeletogenesis,
indicating a role in regulating biomineralization (Di Bernardo
et al., 1999; Cavalieri et al., 2003; Duloquin et al., 2007; Rottinger
et al., 2008; Cavalieri et al., 2011; Adomako-Ankomah and
Ettensohn, 2013). Gene products that specifically regulate primary
PMC positioning but not biomineralization, i.e. dedicated skeletal
patterning genes, remain largely undiscovered.
In contrast to ectodermal skeletal patterning cues, ectodermal
specification is better understood. Specification of the ventral
ectoderm relies on the asymmetric activation of Nodal
expression and signaling, which, in turn, depends on
asymmetric p38 activation (Duboc et al., 2004; Flowers et al.,
2004; Bradham and McClay, 2006). Nodal induces the ventral
expression of BMP2/4, which signals only outside the ventral
region to induce dorsal ectodermal specification (Angerer et al.,
2000; Duboc et al., 2004). A neurogenic ciliated band develops
at the dorsal-ventral (DV) boundary; this default ectodermal
state is suppressed by Nodal and BMP2/4 signaling (Duboc
et al., 2004; Bradham et al., 2009; Lapraz et al., 2009; Yaguchi
et al., 2010). Gene regulatory network models describing
ectodermal specification are now established (Su et al., 2009;
Saudemont et al., 2010; Barsi et al., 2015), as are initialReceived 1 August 2015; Accepted 5 January 2016
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mathematical models describing movement of BMP2/4 in sea
urchin embryos (van Heijster et al., 2014).
In this study, we present results from an RNA-Seq-based screen
with which we identify novel skeletal patterning genes. LOF
analyses indicate that each tested gene is required for normal PMC
positioning and skeletal patterning, but not for biomineralization.
One such candidate, SLC26a2/7, is a sulfate transporter that is
required for a ventral accumulation of sulfated proteoglycans
(SPGs) in Lytechinus variegatus. Our results demonstrate that
ventral SPGs are required to attract PMCs into the ventral portion of
the PMC ring, and thereby, to pattern the ventral skeletal rods.
RESULTS
p38 MAPK inhibition in the ectoderm elicits skeletal
patterning defects
The goal of this study was to identify novel skeletal patterning genes
in the ectoderm of the sea urchin embryo. This project was initiated
by the observation that L. variegatus embryos cultured in the
presence of SB203580 prior to gastrulation develop a strongly
mispatterned skeleton (Fig. 1A) (Bradham and McClay, 2006).
SB203580 (SB) is a highly specific inhibitor of p38 MAPK (Davies
et al., 2000). To test whether SB acts on the ectoderm or the PMCs,
we microsurgically generated chimeric embryos in which either the
PMCs or the ectodermal hull only were exposed to SB (Fig. 1B).
This approach was previously used to show ectoderm-specific
skeletal patterning defects with NiCl2 (Armstrong et al., 1993) and
overexpression of the homeobox protein Msx (Tan et al., 1998).
Patterning defects were observed only in chimeras in which the hull
was exposed to SB (Fig. 1C,D), indicating that SB specifically
impacts the ectoderm and not the PMCs to induce skeletal
patterning defects. PMC migration was disorganized in SB-treated
embryos compared with controls (Fig. 1E,F), consistent with
defects in the ectodermal cues that mediate PMC positioning.
Interestingly, the PMCs in SB-treated embryos progressively
displayed excessively numerous and elongated filopodia during
gastrulation, which were most conspicuous at late gastrula (LG)
stage (Fig. 1F). Filopodia extended by the PMCs are likely to be
conduits of information between the ectoderm and the PMCs
(Miller et al., 1995; Lyons et al., 2012); the abnormal filopodia
observed in SB-treated embryos probably reflect a response to
abnormal ectodermal patterning information.
Interestingly, the defect in skeletal patterning, its ectodermal
dependence and the abnormal filopodia induced by SB treatment are
each similar to the effects of NiCl2 (Hardin et al., 1992; Armstrong
et al., 1993; Miller et al., 1995). Thus, both nickel- and SB-treated
embryos exhibit characteristics consistent with abnormal ectodermal
patterning information, including the spatial disordering of the PMCs,
their excessive filopodial extensions and the abnormal skeletons
eventually produced. These results suggested the hypothesis that at
least some skeletal patterning genes are similarly perturbed in the
ectoderm of both nickel- and SB-treated embryos. We reasoned that
the simplest explanation for these observations is a loss of ectodermal
patterning gene expression with nickel or SB, since PMCs appear to
lack a complete set of migration cues (Fig. 1E,F); however, we
recognized that it is also possible that increased and/or ectopically
expressed cues are responsible for these patterning defects.
SB and nickel have opposite effects on ectodermal
specification and differentiation
Treatment with nickel provokes ectodermal ventralization, whereas
SB treatment blocks it (Hardin et al., 1992; Bradham and McClay,
2006). We confirmed these effects by comparing the expression of
dorsal and ventral specification markers, and by labeling the ciliary
band, which is sensitive to DV perturbations (Yaguchi et al., 2010).
Nickel exposure resulted in radial expansion of the ventral marker
nodal, loss of the dorsal marker tbx2/3 and abnormal restriction of
the ciliary band to the posterior region of the embryo (Fig. 1Gb,Hb,
Ib), consistent with ventralization. By contrast, SB exposure
provoked the opposite effects, with a loss of nodal expression,
radial expansion of tbx2/3 and loss of restriction of the ciliary band
(Fig. 1Gc,Hc,Ic), consistent with a pre-ventralized ectodermal state
(Duboc et al., 2004; Bradham and McClay, 2006). These results
indicate that nickel and SB have distinct effects on DV specification
and differentiation in the ectoderm. This conclusion led us to predict
that nickel and SB treatments would provoke reciprocal effects on
the expression of genes involved in DV specification (‘DV genes’)
in the ectoderm, thereby providing a means to discriminate
reciprocally regulated ectodermal DV genes from mutually
regulated skeletal patterning genes.
A differential RNA-Seq screen identifies novel skeletal
patterning genes
The combined observations that Ni and SB each provoke similar
effects on skeletal patterning and opposite effects on ectodermal DV
specification provided an opportunity to identify a subset of
ectodermal skeletal patterning genes, which we predicted would be
regulated similarly by nickel and SB compared with controls and
therefore distinguishable fromDV genes, which we predicted would
be reciprocally regulated by nickel and SB (Fig. 2A). Although the
mutually regulated subset of genes might not represent all skeletal
patterning genes, and in fact would exclude any patterning genes
regulated by the DV gene regulatory network, we reasoned that this
approach was still likely to identify novel patterning genes. We
further predicted that most non-ectodermal genes would be
unaffected by either treatment (Fig. 2A). Finally, we predicted
that ectodermal skeletal patterning genes would encode proteins that
are associated with the cell surface or secreted, as mediators of
communication between the ectoderm and the PMCs.
Following this rationale, we used RNA-Seq to compare the
transcriptomes from control, nickel- and SB-treated embryos at
the LG stage, and focused on genes downregulated by nickel
and SB. An early transcriptome assembly using SOAPdenovo
was used to identify candidates downregulated by both nickel and
SB (‘mutually downregulated’, cut-off ≥twofold), which
corresponded to a minority subset of the total transcriptome
(Fig. S1A), and which, for the identifiable subset, exhibited an
approximately twofold enrichment of sequences encoding cell
surface or secreted proteins (Fig. S1B). Multiple candidates for
further analysis were selected based on this early assembly, along
with one candidate that was upregulated by both treatments in the
initial assembly (Fig. S1C; Table S1; see supplementary Materials
and Methods for the rationale for candidate selection).
Subsequently, an improved, final assembly was generated using
the SOAPdenovo-Trans (Fig. 2B-F). The fraction of mutually
downregulated sequences increased in the final assembly,
reflecting substantially improved gene models and annotations,
whereas enrichment of cell surface and secreted sequences was
maintained (Fig. 2C,D). The directionality of the expression level
differences for the selected candidates was maintained in the final
assembly, although in some cases, the magnitude of change was
reduced such that most candidates from the initial assembly were
retained in the final assembly with a cut-off of 1.5-fold (Fig. 2E,F).
The candidate genes identified in the final assembly are listed in
Table S2. Genes previously implicated in regulating skeletal
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patterning exhibited reciprocal rather than mutual regulation by
nickel and SB (Fig. 2E,F), indicating first that the identified genes
are regulated distinctly from previously described patterning
genes, and second, that the candidate pool does not represent a
comprehensive set of patterning genes. iPAGE analysis (Goodarzi
et al., 2009) shows that GO terms associated with cell surface or
extracellular processes (i.e. GPCRs, scavenger receptors and
transporters) are enriched in the mutually downregulated set of
transcripts (Fig. 2G). We also observed enrichment of GO terms
associated with fatty acid biosynthesis and sulfotransferase
activity.
To gain a more comprehensive view of the impact of nickel and
SB on gene expression, we examined the expression of previously
characterized genes (Fig. S1D-H). As expected, most genes
involved in ventral ectodermal specification were upregulated by
nickel and downregulated by SB (Fig. S1D). Genes involved in
dorsal ectodermal specification were downregulated by nickel, and
not strongly impacted by SB (Fig. S1E). Most endomesodermal
specification genes were not strongly affected by nickel or SB
(Fig. S1F-H), with the exception of known dorsal and ventral
secondary mesenchyme cell (SMC) genes, which responded
reciprocally to nickel and SB, and coelomic and germline genes,
which were downregulated by SB. Among this set of 81 genes, only
one, SM30, exhibited downregulation by both nickel and SB. SM30
is a biomineralization gene whose protein products are incorporated
into the skeleton. Surprisingly, SM30 was recently shown to be
dispensable for normal skeletogenesis (Wilt et al., 2013). Thus,
most of the known specification and differentiation genes responded
as expected to nickel and SB treatments. To investigate the behavior
of the metabolic network in nickel- and SB-treated embryos, we
performed an iPath 2.0 analysis (Yamada et al., 2011), which
indicates that very few metabolic genes were affected by either
treatment (Fig. S1I,J). Together, these results are consistent with the
predictions schematized in Fig. 2A.
We selected nine candidate genes for functional analysis based
on their ‘double-down’ expression profiles. One final candidate
gene was selected based on its ‘double-up’ behavior. Morpholino
(MO)-mediated knockdown of all ten genes resulted in skeletal
patterning but not biomineralization defects, suggesting that the
extracellular fraction of the mutually regulated genes is enriched
for skeletal patterning cues. We focused on four of these genes
for further analyses and obtained their full-length clones (Fig. S1C).
Phylogenetic analyses confirmed the annotations for these
candidate genes (Fig. S2B-G). To perform functional analyses,
we designed translation- or splice-blocking MO antisense
oligonucleotides (Fig. S2A). In all four cases, LOF resulted in
plutei that displayed dramatic, previously unreported skeletal
patterning defects (Fig. 2H,I), indicating that each candidate is
required for normal skeletal patterning. The defective skeletal
patterns presented reflect commonly observed phenotypes for each
of the indicated MOs based on extensive skeletal scoring and
include ventral defects induced by SLC MO, right side defects
Fig. 1. Ectodermal p38 MAPK inhibition results in skeletal patterning
defects and blocks ventral ectodermal specification. (A) Morphology
(Aa) and skeletal birefringence (Ab) of a sea urchin embryo treated with
SB203580 (SB) prior to gastrulation. (B) Schematic depicting PMC
transplants, with Rhodamine-labeled donor PMCs transplanted into unlabeled
recipient ectodermal hulls at mesenchyme blastula stage. (C,D) Morphology
(Ca,Da), skeletal pattern (Cb,Db) and PMC positioning (Cc,Dc) is shown for
chimeras in which only the donor PMCs (C) or the recipient hull (D) was
exposed to SB. (E,F) PMC-specific immunostaining shown in control (E) and
SB (F) embryos at early (Ea,Fa), mid (Eb,Fb) and late gastrula (Ec,Fc) stages
(14, 16 and 18 hpf, respectively). (G,H) Whole-mount in situ hybridization for
ventrally expressed nodal (G) and dorsally expressed tbx2/3 (H) in control (Ga,
Ha), Ni (Gb,Hb) and SB (Gc,Hc) embryos at late gastrula stage. (I) The dorsal-
ventral ectoderm boundary is shown by ciliary band-specific immunostaining in
control (Ia), Ni (Ib) and SB (Ic) pluteus stage larvae (48 hpf).
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induced by NFLMO, left side defects induced by BMP5-8MO, and
midline defects induced by LOX MO (see Fig. S7A-C for scoring
rubric). Detailed analyses for LOX, NFL and BMP5-8 will be
presented in follow-up studies. Notably, while both Ni and SB
treatments provoked radialized skeletons that reflect DV
perturbations, none of the candidate LOF phenotypes were
radialized. In addition, none of the morphants exhibit a block to
biomineralization, since all the PMCs within these larvae were
Fig. 2. A differential RNA-Seq-based screen
identifies skeletal patterning genes in the sea
urchin embryo. (A) Schematic representation of the
rationale for the screen. (B) Box plots depicting the
range of expression values following normalization of
RNA-Seq data. (C,D) Pie charts display differential
analysis results from the final RNA-Seq assembly.
From the mutually downregulated set of scaffolds
(C, red), the intra- and extracellular localization of the
identifiable subset is shown (D). (E,F) Differential
expression values are shown in MA plots for Ni (E) and
SB (F) compared with control. Mutually upregulated
(red) and downregulated (blue) scaffolds are shown.
Validated skeletal patterning candidates and other
genes implicated in skeletal patterning are indicated.
(G) iPAGE analysis showing enrichment of GO terms
as a heat map with bins reflecting the range of ratios of
the average gene expression in Ni and SB embryos
compared with control expression. Mutually
downregulated bins are to the left and mutually
upregulated bins are to the right. (H-L) Loss-of-function
analysis for four skeletal patterning candidate genes is
shown as morphology (DIC; H), skeletal pattern (I),
PMC immunostaining at late gastrula stage (18 hpf; K)
and PMC (J) and ciliary band (L) immunostaining at
pluteus stage (48 hpf), for embryos injected with the
indicated MO. Corresponding phase-contrast images
are displayed as insets. The pluteus stage PMC stain
and ciliary band control embryos (Ja,La) were
uninjected.
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associated with skeletal elements (Fig. 2J). Thus, the candidate LOF
effects are distinct from those produced by knockdown of VEGF/R,
Wnt5a, Otp, Pax2/5/8 or FGF, because each of the latter LOFs
blocks biomineralization, resulting in larvae that lack skeletons
entirely (Di Bernardo et al., 1999; Cavalieri et al., 2003; Duloquin
et al., 2007; Rottinger et al., 2008; Cavalieri et al., 2011; Adomako-
Ankomah and Ettensohn, 2013; McIntyre et al., 2013).
Furthermore, each candidate LOF resulted in perturbed PMC
organization at the LG stage (Fig. 2K), indicating that each gene is
required for normal PMC positioning. Finally, we tested ectodermal
DV specification by labeling the ciliary band in the LOF embryos.
The results show that the ciliary band is restricted normally in each
morphant (Fig. 2L), indicating that DV specification of the
ectoderm is normal in candidate gene morphants. These results
show that the skeletal patterning defects observed in candidate gene
morphants do not result from DV perturbations, consistent with
their non-radialized phenotypes. These MOs were variably
penetrant, ranging from 58 to 88% of the injected embryos
(Fig. S3A). The specificity of these MOs is demonstrated by
phenotypic rescues when exogenous, nonbinding cognate mRNA
LvNfl, LvBmp5-8 and LvLox was coinjected (Fig. S3B-D); SLC
rescue experiments are presented in Fig. 3T-X. RT-PCR analysis
indicates that the splice-blocking SLC MO, NFL MO and BMP5-8
MO each disrupt normal splicing (Fig. S3E-G). SLC MO and
BMP5-8 MO each efficiently blocked the formation of the targeted
splice junction; sequencing of the mis-spliced bands confirms that
SLCMO inhibits inclusion of exon 14 as expected, whereas BMP5-
8 MO inhibits the inclusion of exons 2 and 3. NFL MO was less
efficient at inhibiting splicing; sequence analysis of the mis-spliced
band indicates that only 46 bp at the 3′ end of the targeted exon were
excluded; this loss resulted in a frameshift of the downstream
sequence. Together, these results demonstrate that the RNA-Seq
screen successfully identified novel genes that are required for
normal skeletal patterning and PMC positioning, but not for
ectodermal DV specification.
LvSlc26a2/7 encodes a sulfate transporter that is required
for production of sulfated proteoglycans
Of the four candidates highlighted herein, SLC LOF produced the
most dramatic effects, including losses of primary skeletal elements
(Fig. 2Hb,Ib). SLC was therefore selected for more extensive
analysis. SLC was annotated as a member of the SLC26 family of
transmembrane ion transporters. Phylogenetic analyses and
sequence alignments place this gene between the vertebrate
SLC26A2 and SLC26A7 genes (Fig. S2B and Fig. S3B); we will
therefore refer to this gene as LvSlc26a2/7 (SLC). Domain analysis
shows that SLC encodes a 10-pass transmembrane protein with
domains characteristic of sulfate transporter genes (Fig. S4A). At
LG stage, SLC is expressed in the ventral ectoderm, extending from
the posterior to the anterior pole, as well as in the blastopore and
endoderm (Fig. 3A). SLC expression is maintained throughout early
development and is downregulated following gastrulation (Fig. 3B);
this expression profile agrees with that of its S. purpuratus ortholog,
which is annotated as SpPrestin (Tu et al., 2014). Thus, SLC is
expressed at the correct time and place to contribute to PMC
positioning and skeletal patterning. SLC expression is
downregulated in nickel- and SB-treated embryos, corroborating
our RNA-Seq results (Fig. 3C and Fig. S5).
The vertebrate SLC26A2 ortholog encodes a sulfate transporter
that is required for the sulfation of proteoglycans (PGs) (Mount
and Romero, 2004). Mutation of SLC26A2 causes the human
disorder diastrophic dysplasia, hallmarked by a range of cartilage
defects and dwarfism; similar effects occur in SLC26A2-
knockout mice, along with skeletal patterning defects. These
defects result from reduced sulfation of PGs during
chondrogenesis, which, in turn, reduces FGF and Ihh signaling,
interfering with skeletal growth (Rossi et al., 1998; Mount and
Romero, 2004; Forlino et al., 2005; Gualeni et al., 2010). These
findings suggested that LvSLC is also a sulfate transporter
responsible for the sulfation of PGs. We tested this by performing
Alcian Blue staining using conditions specific for detection of
sulfated proteoglycan (SPG). In control embryos, Alcian Blue
staining is strongest in the ventral ectoderm, extending from the
posterior to the anterior pole and in the blastopore (Fig. 3D,
Fig. S6). The ventral accumulation of SPGs closely matches the
spatial expression of LvSLC (compare Fig. 3A and D). By
contrast, SLC MO-injected embryos exhibited uniformly low
SPG levels (Fig. 3G), indicating that SLC is required for the
ventral SPG accumulation. To corroborate these results, we tested
the effects of culturing embryos in sulfur-free or chlorate-
supplemented sea water. We reasoned that removing external
sulfate should phenocopy loss of a sulfate transporter; chlorate
inhibits the addition of sulfate to the universal sulfate donor
PAPS, thereby blocking proteoglycan sulfation (Baeuerle and
Huttner, 1986). Previous work showed that sulfated
proteoglycans regulate DV specification in sea urchin embryos
(Bergeron et al., 2011) and consistent with those results, we found
that removal of sulfur or addition of chlorate to early embryos
perturbed the DV axis (not shown). To avoid this, we began each
treatment at 10 h post fertilization (hpf ), after the DV axis is
established, but before PMC ingression and migration (Bradham
and McClay, 2006; Piacentino et al., 2015). Both treatments
provoked uniformly low SPG levels, similar to results with SLC
MO (Fig. 3E,F). We corroborated the spatial distribution of SPGs
in controls and in no-sulfur embryos by staining with Cuprolinic
acid, which selectively labels SPGs (Fig. S6) (Chan et al., 1992).
When we overexpressed SLC, the embryos displayed uniformly
high SPG levels in the ectoderm (Fig. 3H); this effect was
mimicked by culturing embryos in sea water containing increased
sulfate concentrations (Fig. 3I). Because of embryo-to-embryo
variability, we could not quantitate the Alcian Blue signal across
populations; instead, we calculated the ventral-to-dorsal signal
difference within individuals, then averaged that ratio (Fig. 3J).
The results show that control embryos reproducibly exhibited
higher ventral SPG levels, whereas all the treated embryos
showed significantly reduced DV ratios. These results
demonstrate that SLC is required to establish ventral SPG
accumulation.
Ventral SPGs are required for ventral skeletal development
We next examined larval skeletal patterning with our suite of
perturbations. Because specific skeletal patterning defects varied
from pluteus to pluteus, we comprehensively scored skeletal
patterns in each perturbant, including the presence and absence of
each rod, defects in rod orientation, and rod transformations or
duplications (Fig. S7A-C). No-sulfur, chlorate and SLC MO each
resulted in frequent bilateral loss of the primary skeletal elements
known as the ventral transverse rods (VTs) (Fig. 3L-N,Q; red
arrows and red elements in schematics). Although other skeletal
elements were also perturbed by the suite of SPG perturbations,
the VTs were most specifically perturbed among the primary
skeletal elements, and were the only element for which the impact
of all the SLC/SPG perturbations correlated (Fig. S7D). The
absence of the VTs correlated strongly with the occurrence of
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‘midline defects’, referring to skeletons with no central elements
(Fig. S7E). The VTs initially arise along the posterior ventral
ectoderm at the LG stage, coinciding with the location of high
SPG levels in controls (see Fig. 3D and Fig. S7A-C). These
results indicate that SLC and SPGs are required for VT
development. High-sulfate treatment and SLC mRNA injections
provoked the development of extra VTs, albeit at a low frequency
(Fig. 3O,P,R). Although SLC mRNA and high sulfate provoked
Fig. 3. slc26a2/7-dependent ventral
sulfated proteoglycans are required for the
formation of the ventral transverse
skeletal elements. (A) Spatial expression of
slc26a2/7 (red, slc) and ventral marker
chordin (green, chd) is shown at late gastrula
stage in posterior (Aa) and lateral (Ab) views.
Corresponding DIC images are shown as
insets. (B) Relative temporal expression of
slc26a2/7 is displayed as normalized ΔCT
values at 11 developmental timepoints
ranging from egg to pluteus stages, as means
±s.e.m. (C) slc26a2/7 expression levels in Ni
and SB embryos compared with controls at
late gastrula stage are shown as means±s.e.
m. (D-I) Alcian Blue staining of sulfated
proteoglycans at late gastrula stage with the
indicated treatments, shown in posterior (top
panels) and lateral (bottom panels) views.
Images were pseudocolored using the
indicated key to highlight differences in
staining intensity. (J) Relative Alcian Blue
staining is displayed as the ratio of ventral-
dorsal staining intensity in control and
perturbed embryos, and is shown asmean±s.
e.m.; two-tailed Student’s t-test *P<0.05,
**P<0.005, ***P<0.0005 compared with
control; n≥10 for all conditions. (K-P) Pluteus
stage (48 hpf) morphologies and skeletal
patterns are shown for the indicated
treatments. The bottom panel shows skeletal
schematics, with the ventral transverse (VT)
elements indicated in red. Filled or open red
arrows indicate VT presence or absence,
respectively. (Q,R) Quantitation of the
frequency of VT loss (Q) and gain (R) with the
indicated treatments. (S) Quantitation of the
fraction of phenotypic embryos resulting from
treatment time courses with no sulfur or
chlorate. (T-W) Morphology and skeletal
patterns for embryos injected with SLC MO
(U), mRNA (V) or combination (W). Filled or
open red arrows indicate VT presence or
absence, respectively. (X) Quantitation of VT
loss in the SLC rescue experiments. The SLC
MO dose was held at 1.33 mM and mRNA
dose was varied as indicated.
708
RESEARCH ARTICLE Development (2016) 143, 703-714 doi:10.1242/dev.129312
D
E
V
E
LO
P
M
E
N
T
VT gains less frequently than VT losses (Fig. 3Q-R), VT gains
were never observed in SLC/SPG LOF embryos, and so their
occurrence with the SLC/SPG gain-of-function (GOF) embryos is
noteworthy. SLC/SPG GOF also resulted in the duplication and
transformation of other skeletal elements (Fig. S7E). The
formation of other skeletal elements was also inhibited by SLC/
SPG LOF and GOF (Fig. S7D); however, these defects did not
correlate across the treatments and occurred in secondary skeletal
elements, suggesting that the principal defect in SLC/SPG
perturbants is the loss of the primary VT skeletal elements. To
define the developmental time interval during which SPGs are
required for skeletal patterning, we performed treatment time
courses with no sulfur or with chlorate. Treatments at 10 hpf
resulted in the highest frequency of skeletal patterning defects and
the penetrance of this effect decreased during gastrulation
(Fig. 3S). Treatment at 16 hpf resulted in VT defects (not
shown), indicating that their patterning occurs during gastrulation.
These results show that ventral SPGs are required during
gastrulation for the formation of the VTs. Rescue experiments
were performed by co-injection of SLC MO and SLC mRNA, and
show that exogenous SLC mRNA rescues VT formation in
morphants (Fig. 3T-X), indicating that re-addition of SLC mRNA
effectively restores the most consistent patterning defect, and that
SLC MO-mediated loss of VTs is not an off-target effect.
Ventral SPGs are necessary and sufficient to attract PMCs
ventrally
We next examined PMC positioning at the LG stage with our suite
of perturbations. As with the skeletal patterning defects, we
observed variable PMC positioning defects. We therefore
established a PMC scoring approach, for which we extracted
PMC coordinates from confocal image stacks, then modeled the 3D
position of each PMC. Tbx2/3 is dorsally expressed in all three germ
layers, and thus is expressed in dorsal, but not ventral, PMCs (Croce
et al., 2003; Gross et al., 2003). We used ectodermal Tbx2/3
expression as a dorsal landmark to orient each 3D model, and
examined each confocal slice in the stack to score each PMC for
Tbx2/3 expression.
SLC MO injection resulted in a significant reduction in the
fraction of ventrally positioned PMCs (Fig. 4Ce, red; E). Treatment
with no sulfur or chlorate similarly provoked a significant reduction
in ventral PMC positioning (Fig. 4Cc,d,E). This agrees with
previous studies on sulfate-deprived embryos, which exhibited
defective PMC migration (Katow and Solursh, 1981). Conversely,
SLC mRNA provoked a significant increase in the fraction of
ventrally positioned PMCs, as did sulfate-supplemented sea water
(Fig. 4Cf,g,E). These results correlate well with the skeletal
patterning defects, since the PMCs in the ventral ring produce the
VTs (see Fig. S7A-C). As SPG loss (no sulfur, chlorate, or SLC
MO) blocks ventral PMC localization and VT formation, whereas
SPG gain (SLC mRNA or high sulfate) promotes excessive ventral
PMC localization and VT formation, we conclude that ventral SPGs
provide an attractive cue that is necessary and sufficient for ventral
PMC localization and VT formation. Thus, SLC is a primary ventral
skeletal patterning gene.
During this analysis, we also observed an unexpected change in
Tbx2/3 expression within the PMCs. In control and control MO-
injected embryos, almost none of the dorsal PMCs were Tbx2/3-
negative, whereas surprisingly, SPG loss and gain each provoked a
striking and significant increase in the percentage of Tbx2/3-
negative PMCs in the dorsal ring (Fig. 4D,F). These results indicate
that the normal concentration of ventral SPGs is required for robust
induction of Tbx2/3 expression in the dorsal PMCs, whereas
deviations above or below that level reduce Tbx2/3 expression in the
dorsal PMCs.
Fig. 4. SPGs are necessary and sufficient to attract PMCs ventrally.
(A,B) Localization of PMCs (A,B; red) and dorsal Tbx2/3 expression (B; green)
is shown in late gastrula stage embryos with the indicated treatments.
(C,D) PMC models reflecting 3D coordinates extracted from image data and
Tbx2/3 expression scores are shown to depict the PMC domains (C) and
Tbx2/3 expression within the PMCs (D). (E,F) Quantitation of the fraction of
ventral PMCs (E) and the fraction of dorsal ring Tbx2/3-negative PMCs per
embryo (F), shown as mean percentages±s.e.m.; two-tailed Student’s t-test
*P<0.05, **P<0.01, ***P<0.001, n.s., not significant compared with control.
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Skeletal patterning defects downstream from SPG
perturbation do not reflect inhibition of VEGF signaling
To determine whether SPG perturbations impact the expression of
genes implicated in skeletal patterning, we performed qPCR
analysis of LG stage embryos with our suite of perturbations
(Fig. S8). Of these, LvPax2/5/8 expression was upregulated only by
sulfur-free ASW, whereas changes in expression of LvWnt5a and
LvUnivin were below the threshold for significance (Fig. S8).
However, the expression of LvVEGF and LvVEGFR was increased
by several of the perturbations (Fig. S8). VEGF is an ectodermally
expressed signal and VEGFR is expressed by the PMCs,
implicating VEGF signaling as a patterning cue (Duloquin et al.,
2007; Adomako-Ankomah and Ettensohn, 2013). Spatially, vegf
expression appeared similar to controls in SLC MO and SLC
mRNA embryos, but was increased by no-sulfur, chlorate and
increased sulfate (Fig. 5A). vegf expression appears to be ventrally
expanded in chlorate embryos (Fig. 5Ac), despite the lack of ventral
PMC migration in these embryos (Fig. 4). vegfr expression showed
a similar profile, appearing normal in SLC perturbants, but
abnormal in chemical perturbants, with chlorate and no-sulfur
treatments compressing vegfr to the PMC clusters, and increased
sulfate expanding vegfr to the PMC ring (Fig. 5B). It is possible that
the differences between the SLC perturbants and the chemical
perturbants reflect the extent of penetrance of their effects.
Fig. 5. SPG perturbations elicit skeletal patterning defects that are distinct from VEGF inhibition. (A-C) Expression of vegf (A, red) and vegfr (B, green) is
shown in late gastrula stage control embryos and in embryos following the indicated SLC/SPG perturbations. qPCR results are shown in Fig. S8. (D-F)
Morphology (D), skeletal patterns (E) and schematics (F) for control plutei (Da,Ea,Fa) and plutei developed from embryos treated with axitinib at 16 hpf (Db,Eb,
Fb). The schematics emphasize the anal rods (ARs, red). (G,H) Skeleton scoring analysis scores comparing SLC/SPG perturbations with axitinib treatment are
shown for the VTs (G) and the ARs (H). Complete scoring results are shown in Fig. S7D,E.
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LvSlc26a2/7 is unlikely to encode the sole sulfate transporter in the
embryo; therefore, chemical perturbations probably have more
broad-ranging effects than molecular perturbation of a single sulfate
transporter. For example, sulfur-free sea water should block entry of
all sulfur and chlorate should block all PG sulfation; thus, each is
likely to produce a stronger effect than SLC MO.
Increased VEGF expression levels likely indicate a compensatory
response to inhibition of VEGF signaling (Adomako-Ankomah and
Ettensohn, 2013), suggesting that VEGF signaling requires SPGs.
Because SPGs are well known to function as signal transduction co-
receptors (Baeg and Perrimon, 2000; Sarrazin et al., 2011), we
tested the possibility that SPGs are required for VEGF signaling by
comparing the patterning defects induced by SLC/SPG LOF and
VEGFR LOF, using the VEGFR inhibitor axitinib (Bhargava and
Robinson, 2011). Axitinib treatment at time points prior to 16 hpf
blocked skeletogenesis; we therefore exposed embryos to axitinib at
16 hpf, then scored their skeletal defects at pluteus stage (Fig. 5D-
F). Axitinib induced an overlapping yet distinct profile of skeletal
patterning defects in comparison to SLC/SPG perturbation.
Although it inhibited VTs in approximately 20% of embryos,
midway between the effects of SLC/SPG loss and gain (Fig. 5G),
axitinib did not induce midline defects, unlike SLC/SPG
perturbants (Fig. S7E). Unlike SLC/SPG perturbations, axitinib
strongly impacted the anal rods (ARs) (Fig. 5Fa, red elements),
which were absent in 100% of axitinib-treated embryos, but more
modestly impacted by SLC/SPG perturbation (Fig. 5Fb,H). This
finding is in good agreement with previous studies (Adomako-
Ankomah and Ettensohn, 2013). Axitinib also provoked frequent
misorientation of the body rods (BRs), such that they were
approximately parallel, rather than converging at the dorsal apex
(Fig. 5D-F, black elements). This reflects an anterior-posterior (AP)
rotation defect (Fig. S7C), which is the only orientation defect
observed in axitinib-treated embryos. By contrast, parallel BRs were
observed only rarely with SLC/SPG perturbations, which provoke a
range of orientation defects (Fig. S7E). Thus, in multiple respects,
the skeletal patterning defects in SLC/SPG perturbants are distinct
from those induced by axitinib. In contrast to these differences,
axitinib and SLC/SPG LOF provoked similar losses of the anterior
secondary elements (the ORs and RRs) (Fig. S7D). These results
indicate that loss of VEGF signaling does not account for the SLC/
SPG perturbation-induced ventral skeletal patterning defects,
although SPGs and VEGF might cooperate in patterning the
anterior secondary skeleton.
DISCUSSION
In this study, we hypothesized that nickel and SB mutually regulate
at least a subset of ectodermal skeletal patterning genes, and that this
could be a basis for discriminating that subset of genes from DV
specification genes, which we predicted to be reciprocally regulated
by nickel and SB (Fig. 1). We identified such mutually regulated
candidate genes and functionally tested them. Since all of the tested
candidates provoked skeletal patterning defects upon their LOF, the
results demonstrate that our hypothesis was supported. We present
several novel, validated skeletal patterning genes and a wealth of
untested candidates to pursue in future studies (Fig. 2). We also
demonstrate that the sulfate transporter LvSLC26a2/7 is required to
establish ventral SPG accumulation during gastrulation, to attract
PMCs ventrally, and for development of the VT skeletal rods (Figs 3
and 4). We observed similar inhibition of PMC migration and VT
development by blocking either sulfur uptake with sulfur-free sea
water or proteoglycan sulfation with chlorate. Conversely, SLC
overexpression or high-sulfate treatment led to increased global
SPGs, excessive ventral PMC migration and, in some cases, the
production of extra VTs. The reciprocal effects of these
perturbations on ventral PMC attraction and skeletal patterning
strengthen the conclusion that SLC-dependent SPGs provide a cue
that directs PMCs ventrally and patterns the ventral transverse
skeletal elements.
Previous studies have shown that manipulating the number of
PMCs within the embryo has no effect on skeletal patterning, such
that a substantially increased complement of PMCs migrates to the
normal ring-and-cords arrangement and produces a normal skeleton,
along which the PMCs are distributed more densely (Ettensohn,
1990). Furthermore, a 50% reduction in PMC number does not
perturb their organization into the ring-and-cords pattern (Ettensohn,
1990). The results herein might appear to contradict that finding,
sincewe demonstrate that reduced numbers of ventral PMCs result in
the loss of the ventral skeletal elements. However, these are two quite
different conditions. In the earlier studies, the ectoderm was not
perturbed, and a normal set of patterning cues was presumably
presented to an abnormally large or small population of otherwise
normal PMCs (Ettensohn, 1990). In this study, an ectodermal
patterning cue was perturbed, and a normal number of PMCs
underwent abnormal migration in response, and failed both to fully
occupy the ventral PMC ring and to produce ventral skeletal rods.
Sulfated proteoglycans are crucial regulators of signaling and cell
migration during development (Iozzo and Schaefer, 2015) and
metastasis (Cattaruzza and Perris, 2005; Theocharis et al., 2010). In
some cases, SPGs function by presenting signaling ligands to their
receptors. For example, in the zebrafish lateral line primordium,
SPGs promote FGF signaling during collective cell migration
(Venero Galanternik et al., 2015). In other cases, SPG receptors
directly bind SPGs to regulate cell migration (Lang et al., 2015;
Neill et al., 2015). In sea urchin embryos, SPGs have been
previously implicated as regulators of PMC migration in vitro and
in vivo (Karp and Solursh, 1974; Katow and Solursh, 1981; Katow,
1986; Solursh et al., 1986; Solursh and Lane, 1988), and as
regulators of skeletal patterning (Sakuma et al., 2011). These results
corroborate our findings, which independently identify SLC-
dependent SPGs as a ventral skeletal patterning cue via an
unbiased screen.
The sea urchin sulfatase HpSulf, although lacking a GOF effect
alone, suppresses the radializing effects of VEGF overexpression,
suggesting that SPGs facilitate VEGF signaling (Fujita et al., 2010).
VEGF signals locally in sea urchin embryos (Duloquin et al., 2007),
consistent with SPGs spatially retaining VEGF through direct
binding. Our results suggest that SPGs and VEGF cooperate during
secondary sea urchin skeletal patterning, although their functions do
not completely overlap. It seems likely that the primary VTelements
are patterned by SPGs in a VEGF-independent manner (Fig. 6),
because inhibition of VEGFR does not strongly impact the VTs or
midline and VEGF expression does not normally coincide spatially
with the VTs (Fig. 5). However, VEGFR and SPG inhibition each
impair anterior secondary skeletal patterning (Fig. 5, Fig. S7), as
does inhibition of LvUnivin (Piacentino et al., 2015). It thus seems
likely that SPGs, VEGF and Univin cooperate to direct secondary
PMC migration (Fig. 6). VEGF knockdown increases VEGF
expression in an apparently compensatory response (Adomako-
Ankomah and Ettensohn, 2013). Such a feedback circuit would
minimally involve a second signal downstream from VEGFR in the
PMCs back to the ectoderm that normally functions to dampen
VEGF expression. Thus, the elevated VEGF expression levels
provoked by chlorate or no sulfur imply a loss of VEGF signaling
and suggest that SPGs are required for VEGF signaling.
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Interestingly, treatment with high sulfate also elevated VEGF
expression, similarly implying that VEGF signaling is inhibited.
Obtaining similar results with both SPG gain and loss could reflect a
scaffolding function for SPGs, in which they jointly present VEGF
and a second required factor to solicit VEGF signaling. In the
absence of SPGs, the signal and factor would not be co-presented,
whereas excessive SPGs levels could bind the signal and factor
independently, and fail to co-present them. Because VEGF, Univin
and SPGs are required for secondary skeletal patterning, we
hypothesize that SPGs scaffold VEGF and Univin, co-presenting
them to the PMCs to promote their secondary migration (Fig. 6).
We also found that SPG loss suppresses Tbx2/3 expression in the
dorsal PMCs (Fig. 4). This result might imply that the Tbx-negative
PMCs did not migrate ventrally in the perturbed embryos, and
instead occupied the dorsal ring. However, SPG gain also suppressed
dorsal Tbx2/3 expressionwhile concomitantly increasing the number
of ventral Tbx-negative PMCs, arguing against that conclusion. Our
results show that dorsal Tbx2/3 expression requires ventral SPGs but
is also suppressed by their excess (Fig. 4), again suggesting a
scaffolding role for ventral SPGs in mediating dorsal Tbx2/3
expression in the PMCs. This is an unexpected result, since the
known ectodermal Tbx2/3 inducers are dorsal genes or signals (Su
et al., 2009; Saudemont et al., 2010); however, little is known about
the regulation of PMC-specific Tbx2/3 expression. We note that
inhibition of ventral specification in L. variegatus embryos results in
radial Tbx2/3 expression (data herein and Piacentino et al., 2015),
suggesting that ventral signals locally suppress Tbx2/3 expression,
which is otherwise globally induced.
This study identifies novel ectodermal cues for patterning the sea
urchin larval skeleton, and for the first time, identifies a cue required
to pattern a specific element of the primary skeleton. It will be
interesting to extend this study to our additional candidates and to
further unravel the basis for sea urchin skeletal patterning.
MATERIALS AND METHODS
Animals, perturbations, surgeries, imaging and skeletal scoring
Adult Lytechinus variegatus sea urchins were obtained from the Duke
University Marine Laboratory (Beaufort, NC) or from Reeftopia (Miami,
FL). Gamete harvesting, embryo culturing and microinjection were
performed as described (Bradham and McClay, 2006). See supplementary
Materials and Methods and Table S3 for additional details. Microsurgeries
to produce chimeras were performed as described (Armstrong et al., 1993).
Larval skeletons were imaged in multiple focal planes, which were manually
recombined into montage images using Canvas (ACD Systems) to present
complete larval skeleton in focus, for clarity. The full set of skeletal images
was used for scoring, as described in Fig. S7.
RNA-Seq, data assembly and analysis
Total RNA was polyA selected, then cDNA libraries were prepared and
sequenced on an Illumina GAII platform. 101 bp paired-end reads were
initially assembled using SOAPdenovo (Li et al., 2010), and finally
assembled using SOAPdenovo-Trans (Xie et al., 2014). Transcriptome
assembly and annotation will be described elsewhere and are available at
NCBI (BioProject accession number PRJNA241187; J. D. Hogan, J.L.K.,
L.L., E.E.S., A. Saji, M. A. Sundermeyer, D. Schatzberg, M.L.P., D.T.Z.,
A.B.C., C. Blumberg, J.I.-S., B. Timmerman, J. G. Grau, N. Irie, A.J.P. and
C.A.B., unpublished data). Differential analysis was performed using
DESeq (Anders and Huber, 2010). MA plots were generated in R (R Core
Team, 2014). GO term enrichment analysis was performed with iPAGE
(Goodarzi et al., 2009) and metabolic maps were generated with iPath 2.0
(Yamada et al., 2011).
Whole-mount in situ hybridization
Full-length riboprobes were labeled with DNP-11-UTP (PerkinElmer) or
digoxigenin (DIG, Roche). In situ hybridization was performed as described
(Bradham et al., 2009; Piacentino et al., 2015).
Immunostaining and confocal microscopy
Immunolabeling was performed as described (Bradham and McClay, 2006;
Piacentino et al., 2015). Primary antibodies include PMC-specific 6a9 (1:5;
from Charles Ettensohn, Carnegie Mellon University, Pittsburgh, PA, USA)
and ciliary band-specific 295 (undiluted; from David McClay, Duke
University, Durham, NC, USA). Secondary antibodies were goat anti-
mouse Cy3 (1:500; Jackson Laboratories) and goat anti-mouse Alexa Fluor
488 (1:500; Molecular Probes). All images are full projections of z-stacks.
3D PMC modeling and analysis
ImageJ was used to manually process confocal z-stack images and to define
the center of each PMC using the multi-point ROI manager; LvTbx2/3
expression was manually scored for each PMC. ROI sets were mapped to 3D
Fig. 6. Model for SLC-mediated skeletal patterning. (A) In gastrulating
embryos, SLC mediates the ventral accumulation of SPGs, which, in turn, are
necessary for the ventral positioning of PMCs and subsequent formation of the
primary ventral transverse rods (red). Anterolateral SPGs might function to
coordinate the presentation of laterally expressed Univin and VEGF
signaling ligands to nearby PMCs to induce their secondary migration (blue).
(B) Schematic representation of the function of SLC and SPGs at the cellular
level in ventral PMC attraction in control (Ba), SPG loss (Bb) and SPG gain (Bc)
conditions.
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space using Blender 2.75 (www.blender.org). For domain assignments,
PMCs were defined as belonging to a cluster if they contacted more than two
other PMCs.
Alcian Blue histochemistry
Sea urchin embryos were fixed in 2.5% glutaraldehyde (Polysciences) and
0.025 M sodium cacodylate (Sigma) in ASW for approximately 24 h, then
washed into staining solution containing 0.3 M magnesium chloride (MP
Biomedicals) and 0.05% Alcian Blue cationic dye (Sigma) at pH 2.5 to
specifically label sulfated functional groups (Scott and Dorling, 1965). After
24 h in staining solution, embryos were washed and imaged. See
supplementary Materials and Methods for details on image processing
and quantitation, and for the Cuprolinic staining method.
qPCR analysis
qPCR analysis was performed as described (Piacentino et al., 2015). qPCR
primer sequences are provided in Table S4.
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